National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Trisomy X is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
Trisomy X is a disorder that affects females and is characterized by the presence of an additional X chromosome. Normally, females have two X chromosomes; however, females with trisomy X carry three X chromosomes in the nuclei of body cells. There are specific physical features (phenotype) associated with this chromosomal disorder. Common symptoms that can potentially occur include language-based learning disabilities, developmental dyspraxia, tall stature, low muscle tone (hypotonia), and abnormal bending or curving of the pinkies toward the ring fingers (clinodactyly). Trisomy X occurs randomly as a result from errors during the division of reproductive cells in one of the parents. This disorder occurs in one in 900 to 1,000 live births.
The symptoms and physical features associated with trisomy X vary greatly from one person to another. Some females may have no symptoms (asymptomatic) or very mild symptoms and may go undiagnosed. Other women may have a wide variety of different abnormalities. It is important to note that affected individuals may not have all of the symptoms discussed below. Affected individuals should talk to their specialists and medical team about their specific case, associated symptoms and overall prognosis.
Trisomy X is often associated with developmental differences and language-based learning disabilities. Intelligence is usually within the normal range. IQ may be 10-15 points below that of siblings or control groups if early intervention has not been successful or begun early enough. Infants and children with trisomy X experience delays in attaining developmental milestones, especially in the acquisition of motor and speech skills. For example, walking may be delayed and affected girls may exhibit poor coordination and clumsiness. Speech and language development is also commonly delayed and may become apparent by approximately one year to 18 months. Girls with trisomy X have an increased frequency of language-based learning disabilities including reading deficiencies such as dyslexia, reading comprehension deficits and/or reading fluency issues in conjunction with other language-based disabilities. They also have developmental dyspraxia which affects learning in every domain. Typically, motor planning skills are deficient, which affects gross and fine motor, speech and language as well as executive function.
During early childhood or adolescence, girls with trisomy X usually exhibit increased height as compared with other girls their age (tall stature). Most girls are at or above the 75th percentile for height with an average height of 5 foot 7 inches.
In some cases, infants with trisomy X may have mild facial abnormalities including vertical skin folds that may cover the eyes' inner corners (epicanthal folds), widely spaced eyes (hypertelorism), and smaller than normal head circumference. Most infants also have decreased muscle tone (hypotonia) and the fifth finger may be abnormally bent or curved mildly, which is called clinodactyly.
Individuals with trisomy X may have an increased incidence of anxiety and attention deficit hyperactivity disorder (ADHD). In some cases, such abnormalities improve with maturity and as the girls reach adulthood. Some individuals have minimal to no behavioral or emotional abnormalities; others have more issues that may necessitate intervention, which is typically only necessary short term. There are no controlled studies on behavioral or emotional abnormalities in trisomy X and the incidence of such conditions is unknown, although they are believed to occur with greater frequency than in the general population. Early detection and treatment are very beneficial for girls with trisomy X. In many cases, these girls have few issues later in life when identified early and treated appropriately.
In most cases, sexual development and fertility are normal. However, reports indicate that some affected females may have abnormal development of the ovaries (ovarian dysgenesis) and/or the uterus; delayed puberty or early onset of puberty (precocious puberty), and/or fertility problems. There have been reports of women with trisomy X developing premature ovarian failure (POF). POF is the loss of function of the ovaries before the age where menopause is expected to begin. POF can cause a decrease in the production of certain hormones and eggs may no longer be released each month.
Less often, additional abnormalities have been described in individuals with trisomy X including kidney abnormalities, such as absence of a kidney (unilateral renal agenesis) or malformation (dysplasia) of the kidneys; recurrent urinary tract infections; seizures; constipation; abdominal pain; flatfeet (pes planus); and pectus excavatum, a condition in which the breastbone is mildly depressed into the chest. Heart (cardiac) abnormalities have also been described in some isolated cases.
Trisomy X is a chromosomal abnormality characterized by the presence of an extra X chromosome. Chromosomes are found in the nucleus of all body cells. They carry the genetic characteristics of each individual. Pairs of human chromosomes are numbered from 1 through 22, with an unequal 23rd pair that normally consists of an X and Y chromosome for males and two X chromosomes for females. Thus, females with a normal chromosomal make-up (karyotype) have 46 chromosomes, including two X chromosomes (46,XX karyotype); they receive one chromosome from the mother and one from the father in each of the 23 pairs.
However, females with trisomy X have 47 chromosomes, three of which are X chromosomes (47,XXX karyotype). Trisomy X is a genetic disorder, but it is not inherited. The presence of the extra X chromosome results from errors during the normal division of reproductive cells in one of the parents (nondisjunction during meiosis). These errors occur randomly for no apparent reason (sporadically). Studies have shown that the risk of such errors increases with advanced paternal age. In most cases, the additional X chromosome comes from the mother. In approximately 20 percent of cases, nondisjunction events occur after conception in the developing fetus (postzygotic nondisjunction).
In some cases, only a certain percentage of an individual's cells may have three X chromosomes, while others have a normal chromosomal make-up (46,XX/47,XXX mosaicism). Evidence suggests that such cases may be associated with milder symptoms and fewer developmental and learning problems, but further research is needed. Variants have also been described in which cells contain four or five X chromosomes (tetra X syndrome and penta X syndrome). Such variants are typically associated with more severe symptoms and findings. (For further information, please see the "Related Disorders" section of this report below.)
Researchers believe that the symptoms and physical features associated with trisomy X develop because of overexpression of the genes that escape normal X-inactivation. Although females have two X chromosomes, one of the X chromosomes is "turned off" and all of the genes on that chromosome are inactivated (X-inactivation). Researchers suspect that the presence of a third X chromosome allows genes normally "turned off" to be expressed. However, the exact manner in which the extra X chromosome ultimately causes the symptoms and physical features of trisomy X is not fully understood.
Trisomy X is a chromosomal disorder that affects only females. Reported estimates concerning the disorder's frequency have varied with the most common estimate being one in 1,000 female births. Because many females with the disorder may have few or no symptoms, they may never be diagnosed. Researchers believe that the disorder is underdiagnosed and that the reported number of cases as reflected in the medical literature is inappropriately low. Researchers believe that only approximately 10 percent of cases are diagnosed. With increased detection, more in depth studies may be conducted and more girls with triple X can be appropriately treated.
Symptoms of the following disorders can be similar to those of trisomy X. Comparisons may be useful for a differential diagnosis.
Tetra X syndrome is a rare chromosomal abnormality in which females have two extra X chromosomes in the nuclei of body cells (48,XXXX karyotype). Mild to moderate intellectual disabilities appear to be more common in this group of girls. Affected individuals also commonly have speech difficulties due to verbal and oral motor dysfunction in association with developmental dyspraxia. In some cases, Tetra X syndrome may also be associated with certain facial abnormalities, such as widely set eyes (ocular hypertelorism), upslanting eyelid folds (palpebral fissures), vertical skin folds that may cover the eyes' inner corners (epicanthal folds), a relatively small jaw (micrognathia), and/or other findings. Other associated features may sometimes include deviation of the fifth fingers (clinodactyly), abnormal fusion of the forearm bones (radioulnar synostosis), webbing of the neck, and/or other abnormalities. Affected females often have incomplete development of secondary sexual characteristics, such as sparse pubic and underarm hair, small breasts, absence or irregularity of menstrual cycles, and, in some cases, underdevelopment of external genitalia. Tetra X results from errors during the division of a parent's reproductive cells (nondisjunction during meiosis).
Penta X syndrome is a rare chromosomal abnormality in which females have three extra X chromosomes in the nuclei of body cells (49,XXXXX karyotype). The condition is typically characterized by certain abnormalities, including short stature, moderate to severe intellectual disabilities, delays in the acquisition of most skills, malformations of the skull and facial (craniofacial) region, and/or other findings. Craniofacial abnormalities may include an abnormally small head (microcephaly), a round face, upslanting eyelid folds (palpebral fissures), malformed ears, a flat nasal bridge, a short neck with a low hairline, and dental abnormalities. Affected individuals may also have widely spaced eyes (ocular hypertelorism), droopy upper eyelids (ptosis), vertical skin folds that may cover the eyes' inner corners (epicanthal folds), thick lips, a small jaw (micrognathia), and/or other abnormalities. Other physical findings associated with Penta X syndrome may include abnormal fusion of the forearm bones (radioulnar synostosis); narrow shoulders; abnormal deviation (clinodactyly) or permanent flexion (camptodactyly) of one or more fingers; heart and/or kidney defects; deficient development of the ovaries and uterus; delayed puberty; and/or other abnormalities. Penta X syndrome results from errors during the division of a parent's reproductive cells. (For more information on these disorders, choose "Penta X" and "Down" as your search terms in the Rare Disease Database.)
Trisomy X may be suspected based upon the identification of characteristic developmental, behavioral or learning disabilities. A diagnosis may be confirmed by a thorough clinical evaluation, a detailed family history, and certain specialized tests such as chromosomal analysis performed on blood samples that can reveal the presence of an extra X chromosome in body cells.
In addition, trisomy X is increasingly being diagnosed before birth (prenatally) based on chromosomal analysis performed subsequent to amniocentesis or chorionic villus sampling (CVS). During amniocentesis, a sample of fluid that surrounds the developing fetus is removed and analyzed, while CVS involves the removal of tissue samples from a portion of the placenta.
Approximately 5-15 percent of women with Turner syndrome also have a 47,XXX karyotype found in certain white blood cells (blood lymphocytes), but the characteristic Turner syndrome karyotype (45,X) in other cells.
Specific therapeutic strategies depend upon several factors including the age of an affected individual upon diagnosis, the specific symptoms that are present and the overall severity of the disorder in each case. Early intervention services are recommended for infants and children diagnosed with trisomy X. Experts advise developmental assessment by age four months to evaluate muscle tone and strength; language and speech assessment by 12 months of age to evaluate expressive and receptive language development; and pre-reading assessment during preschool years prior to first grade to look for early signs of reading dysfunction. An evaluation is recommended to help assess additional learning disabilities and social and emotional problems.
Evidence suggests that affected children are greatly responsive to early intervention services and treatment. Such services can include speech therapy, occupational therapy, physical therapy, and developmental therapy and counseling.
Infants and children with trisomy X should also receive kidney (renal) and heart (cardiac) evaluations to detect abnormalities of those organs potentially associated with the disorder. Adolescent and adult women who exhibit late periods (menarche), menstrual abnormalities, or fertility issues should be evaluated for primary ovarian failure.
Genetic counseling will be of benefit for affected individuals and their families. Additional treatment for this disorder should be targeted at infancy for physical therapy, between 12 and 15 months for speech delay, prior to first grade for early signs of reading dysfunction and by third grade for anxiety and ADHD. Adolescence is challenging for children, and girls with triple X often struggle as they enter middle school years so counseling short term may be necessary to help them during these turbulent years.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. Government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
For information about clinical trials conducted in Europe, contact:
Speicher MR, Antonarakis SE, Motulsky AG. Eds. Vogel and Motulsky's Human Genetics: Problems and Approaches. 4th ed. Springer. New York, NY; 2009:124.
Samango-Sprouse CA. XXX Syndrome (Triple X Syndrome). NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. Philadelphia, PA. 2003:89.
Samango-Sprouse CA Frontal Lobe Development in Childhood. The Human Frontal Lobe: Functions and Disorders, 2nd Edition, Eds. BL Miller, and JL Cummings, Guilford Press, New York, 2007.
Rimoin D, Connor JM, Pyeritz RP, Korf BR. Eds. Emory and Rimoin's Principles and Practice of Medical Genetics. 4th ed. Churchill Livingstone. New York, NY; 2002:1195-1196.
Otter M, Schrander-Stumpel CT, Curfs LM. Triple X syndrome: a review of the literature. Eur J Hum Genet. 2010;18:265-271.
Krusinskie V, Alvesalo L, Sidlauskas A. The craniofacial complex in 47,XXX females. Eur J Orthod. 2005;27:396-401.
Liebezeit BU, Rohrer TR, Singer H, Doerr HG. Tall stature as presenting symptom in a girl with triple X syndrome. J Pediatr Endocrinol Metab. 2003;16:233-235.
Rovet J, Netley C, Bailey J, Keenan M, Stewart D. Intelligence and achievement in children extra X aneuploidy: a longitudinal perspective. Am J Med Genet. 1995;60:356-363.
Raticliffe SG, Pan H, McKie M. The growth of XXX females: population-based studies. Ann Hum Biol. 1994;21:57-66.
Samango-Sprouse CA, Rogol A. XXY: The Hidden Disability and Prototype for Infantile Presentation of Developmental Dyspraxia (IDD). Infants and Young Children. 2002;15:11-18.
Tartaglia NR, Howell S, Sutherland A, Wilson R, Wilson L. A review of trisomy X (47,XXX). Orphanet encyclopedia, 2010. Available at: http://www.ojrd.com/content/5/1/8 Accessed March 25, 2014.
Mayo Clinic for Medical Education and Research. Triple X Syndrome. Nov. 08, 2012. Available at: http://www.mayoclinic.com/health/triple-x-syndrome/DS01090 Accessed March 25, 2014.
March of Dimes Birth Defects Foundation
1275 Mamaroneck Avenue
White Plains, NY 10605
National Dissemination Center for Children with Disabilities (DELETED
1825 Connecticut Ave NW, Suite 700
Washington, DC 20009
National Center for Learning Disabilities
381 Park Avenue South
New York, NY 10016
Chromosome Disorder Outreach, Inc.
P.O. Box 724
Boca Raton, FL 33429-0724
Learning Disabilities Association of America
4156 Library Road
Pittsburgh, PA 15234-1349
International Dyslexia Association
40 York Rd
Baltimore, MD 21204
UNIQUE - Rare Chromosome Disorder Support Group
The Rare Chromosome Disorder Support Group
G1 The Stables
Station Road West, Oxted
Surrey, RH8 9EE
Email: email@example.com or firstname.lastname@example.org
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
PO Box 241956
Los Angeles, CA 90024
Klinefelter Syndrome & Associates
P.O. Box 872
Pine, CO 80470-0872
Focus Foundation, Inc.
PO Box 190
Davidsonville, MD 21035
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email email@example.com
Last Updated: 4/1/2014
Copyright 1995, 1996, 1997, 1998, 2001, 2011, 2014 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.